Press Releases

 
Press Releases
Date Title and Summary View
Apr 8, 2015 NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Krishna Polu, M.D., Chief Medical Officer, will be a speaker at the following conference: Inaugural Neurology Innovation Conference on Sunday, April 19, 2015, at 2:05pm ET in Washington, D.C. Dr. Polu plans to discuss the ...
Apr 8, 2015 NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced the closing of its underwritten public offering of 10,925,000 shares of its common stock a...
Apr 2, 2015 NOVATO, Calif., April 2, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced that it has priced an underwritten public offering of 9,500,000 shares of its common stock...
Mar 30, 2015 NOVATO, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced that it has commenced an underwritten public offering of $75 million of shares of its com...
Mar 11, 2015 NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors approved grants of inducement stock options to purchase an aggregate of 152,867 shares of common stock to six new employees and a grant of 10,714 Restricte...
Feb 26, 2015 Global Net Product Sales for PROCYSBI® of $69.5 Million for 2014 2015 PROCYSBI Revenue Guidance of $80-$90 MillionCompany to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT NOVATO, Calif., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) reported financial results for the fourth quarter and ye...
Feb 23, 2015 NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events meant to celebrate advancements in the field of rare and orphan diseases and to support and strengthen patient communities. The company joins EURORDI...
Feb 18, 2015 NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor conferences: SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day on Monday, February 23, 2015, at the JW E...
Feb 17, 2015 NOVATO, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release fourth quarter and full year 2014 financial results on Thursday, February 26, 2015 after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. ET (1:30 p.m. PT) that day to d...
Feb 10, 2015 NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015 New Treatment Award for PROCYSBI® (cysteamine bitartrate) delayed-release capsules on February 12, 2015 at its 11th Annual WORLD Symposium being he...
Page:
1
... NextLast
= add release to Briefcase